Solutions For Manufacturers

We assist manufacturers in proactively collecting and reviewing end-user experience gained from medical devices or drugs placed on the market


It is extremely costly and labour intensive for Manufacturers to manage medical device and drug safety recalls. These cost approximately 100k and often yield very little feedback with poor outcome data.

Device Link supports Manufacturers with their regulatory obligations for Post Market Surveillance and Post Market Clinical Follow-Up processes. It facilitates end-user notification to both Patients and Healthcare Professionals alike, offering a more cost effective, real-time agile solution to the problem of managing product alerts. Capability to capture real world product feedback from end users.

Device Link is already being actively used within the NHS.
Device Link supports Manufacturers with device demographic data and feedback alongside Patient and Public engagement.

Problems Faced By Manufacturers

At present, many manufacturers do not host an effective post market surveillance system for their medical devices.

These are costly, manual processes with inaccurate records of device users. End-users often unaware of medical device recalls. Absence of traceability and no mechanism to audit numbers of users affected.

Legalities - Manufacturers will be mandated to follow the new medical device Regulations- 2017/745/EU(MDR) and 2017/746/EU)(IVDR) from July 2024 and thus will be unable to fully comply using their current systems.

Current System For Device Recalls

Very expensive to NHS with estimate of £200k/recall issued

With Device Link

Cost of recall to NHS £0

In an increasingly global device market, Manufacturers are more likely than ever to face global responsibility when a device fails.

Recalls which are spread across multiple regions or more than one country are more logistically challenging than concentrated recalls, especially if the manufacturer lacks effective tracking systems.

A costly recall can become unmanageable if the manufacturer can't track unique product identifiers or customer complaints. Proactive and reactive management can be challenging and costly to resolve and/or investigate without visibility into the supply chain.

Manufacturers host mechanisms for the registration of their medical devices based on end-users completing registration warranty cards. These are unreliable processes, inevitably culminating in outdated and inaccurate records of device registers.

During our research into providing the best outcomes for our end users. We reviewed the recommendations with the Cumberlege ReviewFirst Do No Harm and the processes for medical device recalls. The impact on our healthcare services is to ensure that medical devices and drug products are being monitored and tracked and that there is clear communication with our end users.

Evidence has highlighted that there is missing and inaccurate data with the absence of tracking systems for monitoring expiration dates and batch numbers of medical devices and drug products.

The current process:

  • Digital notifications to all medical resources
  • Hospitals, GP practices, Pharmacies etc
  • Time to track patients with the device
  • Product Alerts sent out by trusts etc to relevant NHS parties (time costs -£100k) nationally
  • Overall Cost of an untargeted notification ~£110k
  • Huge waste of time/ Still doesn’t get to the relevant party/end user

Contact us for more information

Leave a contact request

Please see our Privacy Policy.